Evidence
QuantHealth is trusted by the world's largest pharma companies to support their key clinical development decisions. With over 120 simulated trials, at an impressive accuracy rate of 85%, QuantHealth's technology became the world leader in clinical trial simulations.
Broad Coverage Across all Therapeutic Areas,
Clinical Phases and Treatment Modalities
Total
By Modality
By Phase
By Novelty
Prospectively Validated
Predicting trial results before readout, without sponsor data, with 85% accuracy on the primary endpointIMVOKE010:
Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (scchn)
- Simulated Results
- Actual Results
1